At day 28 , the cure rates in a per-protocol analysis were 92 % ( 48/52 ) with AL , 93 % ( 50/54 ) with AS-SMP , 93 % ( 55/59 ) with AS-AQ and 100 % ( 57/57 ) with SP-AQ , with no statistically significant difference between the four treatments .